BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Diagnosis
359 results:

  • 1. Compliance With NCCN Guidelines for Evaluation and Treatment of Anemia Among Patients With Solid Tumors.
    Hufnagel DH; Bos LM; Brown AJ; Prescott LS
    J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38489926
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. prostate cancer in Spain: A retrospective database analysis of hospital incidence and the direct medical costs.
    Darbà J; Ascanio M
    PLoS One; 2024; 19(3):e0298764. PubMed ID: 38451968
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions.
    Mei S; Alchahin AM; Tsea I; Kfoury Y; Hirz T; Jeffries NE; Zhao T; Xu Y; Zhang H; Sarkar H; Wu S; Subtelny AO; Johnsen JI; Zhang Y; Salari K; Wu CL; Randolph MA; Scadden DT; Dahl DM; Shin J; Kharchenko PV; Saylor PJ; Sykes DB; Baryawno N
    Genome Med; 2024 Jan; 16(1):1. PubMed ID: 38281962
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Incidental carcinoma of the prostate in cystoprostatectomy specimens - is it always a toothless lion?
    Dema V; Croitor A; Floruncuţ A; Dema S; Bardan TR; Tăban SM; Barna RA; Natarâş BR; Cumpănaş AA
    Rom J Morphol Embryol; 2023; 64(4):501-507. PubMed ID: 38184830
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Association between sociodemographic factors and diagnosis of lethal prostate cancer in early life.
    Smani S; Novosel M; Sutherland R; Jeong F; Jalfon M; Marks V; Rajwa P; Nolazco JI; Washington SL; Renzulli JF; Sprenkle P; Kim IY; Leapman MS
    Urol Oncol; 2024 Feb; 42(2):28.e9-28.e20. PubMed ID: 38161105
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Do all prostate cancer patients want, and experience shared decision making prior to curative treatment?
    Otrebski Nilsson M; Aas K; Myklebust TÅ; Gjelsvik YM; Haug ES; Fosså SD; Johannesen TB
    Scand J Urol; 2023 Dec; 58():133-140. PubMed ID: 38116675
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Patient-reported prostate cancer treatment regret following primary partial gland cryoablation.
    Lepor H; Rapoport E; Gogaj R; Hernandez H; Wysock JS
    Urol Oncol; 2024 Jan; 42(1):20.e1-20.e7. PubMed ID: 38065805
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients.
    Freedland SJ; Nair S; Lin X; Karsh L; Pieczonka C; Potluri R; Brookman-May SD; Mundle SD; Fleming S; Agarwal N
    World J Urol; 2023 Dec; 41(12):3535-3542. PubMed ID: 37966506
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study.
    Mitchell AP; Dusetzina SB; Mishra Meza A; Trivedi NU; Bach PB; Winn AN
    BMJ; 2023 Oct; 383():e075512. PubMed ID: 37879723
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Feasibility of a three-sided encapsulation procedure based on fascia anatomy in laparoscopic lateral lymph node dissection for middle and low rectal cancer].
    Li WJ; Diao DC; Lin JX; Wang JH; Liao WL; Tang X; Xie JX; Ao L; Zhang XY; Yi XJ; Feng XC; Li HM; Lu XQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Oct; 26(10):968-976. PubMed ID: 37849268
    [No Abstract]    [Full Text] [Related]  

  • 11. Diagnostic Performance of PSMA-Based 18 F-DCFPyL PET/CT in prostate cancer Patients After Definitive Treatment With PSA Level ≤0.2 ng/mL.
    Lu Y; Wilson ZJ; Xu G; Xu Z; Pan T; Wei P
    Clin Nucl Med; 2023 Dec; 48(12):1021-1027. PubMed ID: 37801580
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Neoadjuvant Chemotherapy for Muscle-invasive Bladder cancer in a Lebanese experience: in all aspects.
    Ahmadieh N; Zeidan T; Chebel JA; Haddad FG; Nemr E
    Gulf J Oncolog; 2023 Sep; 1(43):33-39. PubMed ID: 37732525
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The role of gadolinium-based contrast agents in magnetic resonance imaging structured reporting and data systems (RADS).
    Parillo M; Mallio CA; Van der Molen AJ; Rovira À; Dekkers IA; Karst U; Stroomberg G; Clement O; Gianolio E; Nederveen AJ; Radbruch A; Quattrocchi CC;
    MAGMA; 2024 Feb; 37(1):15-25. PubMed ID: 37702845
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Error mitigation enables PET radiomic cancer characterization on quantum computers.
    Moradi S; Spielvogel C; Krajnc D; Brandner C; Hillmich S; Wille R; Traub-Weidinger T; Li X; Hacker M; Drexler W; Papp L
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3826-3837. PubMed ID: 37540237
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Ultrasensitive immunosensor for multiplex detection of cancer biomarkers carcinoembryonic antigen (CEA) and yamaguchi sarcoma viral oncogene homolog 1 (YES1) based on eco-friendly synthesized gold nanoparticles.
    Kiio LK; Onyatta JO; Ndangili PM; Oloo F; Santamaria C; Montuenga LM; Mbui DN
    Talanta; 2024 Jan; 266(Pt 1):124934. PubMed ID: 37454512
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diagnostic Performance and Safety of Positron Emission Tomography with
    Surasi DS; Eiber M; Maurer T; Preston MA; Helfand BT; Josephson D; Tewari AK; Somford DM; Rais-Bahrami S; Koontz BF; Bostrom PJ; Chau A; Davis P; Schuster DM; Chapin BF;
    Eur Urol; 2023 Oct; 84(4):361-370. PubMed ID: 37414702
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Point-of-care diagnostics for rapid determination of prostate cancer biomarker sarcosine: application of disposable potentiometric sensor based on oxide-conductive polymer nanocomposite.
    Yamani HZ; Safwat N; Mahmoud AM; Ayad MF; Abdel-Ghany MF; Gomaa MM
    Anal Bioanal Chem; 2023 Sep; 415(22):5451-5462. PubMed ID: 37389600
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Does a prior cancer diagnosis impact PSA testing? Results from the National Health Interview Survey.
    Lazarovich A; Chandrasekar T; Basnet A; Bratslavsky G; Goldberg H
    Can J Urol; 2023 Jun; 30(3):11551-11557. PubMed ID: 37344467
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Urologists and Lesbian, Gay, Bisexual, Transgender, or Queer Patients: A Survey-based Study of the Practice Patterns, Attitudes, and Knowledge Base of Urologists Toward Their Lesbian, Gay, Bisexual, Transgender, or Queer Patients.
    Xu AJ; Panken EJ; Gonzales-Alabastro CD; Zhang H; Helenowski IB; Murphy AB; Prabhu R; Amarasekera C
    Urology; 2023 Sep; 179():71-79. PubMed ID: 37286139
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Intravoxel incoherent motion predicts positive surgical margins and Gleason score upgrading after radical prostatectomy for prostate cancer.
    Meng S; Gan W; Chen L; Wang N; Liu A
    Radiol Med; 2023 Jun; 128(6):668-678. PubMed ID: 37277573
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 18.